Loading insider details...
Beta
Latest Form 4 (Oct 19, 2026): Exercise/Conversion of 43,735 TVTX shares, $1.18M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 19, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 43,735 | $1.18M |
| Sep 18, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 95,666 | $2.23M |
| May 7, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 22,500 | n/a |
| Apr 16, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 64,000 | n/a |
| Apr 2, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 60,000 | $927.6K |
| Feb 24, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 60,000 | $927.6K |
| Feb 4, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 113,800 | n/a |
| Jan 28, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 8,135 | $125.8K |
| Oct 30, 2025 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 92,872 | $1.44M |
| May 6, 2025 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 18,924 | n/a |